| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a40388051ab19b9f810ce37424400ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f140361615a956e8b226485556e8bab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad5f3576dd2b21463b62cc86b1500a8c |
| filingDate |
2001-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72b6b379241a11b8b2de3e967b5ca14b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_590aeafd747a9c5c38b26931c8790dc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5617fb5c7969e900e923fb71bad2ac05 |
| publicationDate |
2002-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
UA-47328-A |
| titleOfInvention |
METHOD OF TREATMENT OF CHRONIC TOXICALLERGIC HEPATITIS IN PATIENTS WITH TUBERCULOSIS |
| abstract |
A method of treating chronic toxicoallergic hepatitis in patients with tuberculosis includes the introduction of lipotropic drugs and antioxidants. Silicon enterosorbents are also administered in the form of 1-2% suspension orally in 200-250 ml for 10-14 days and cycloferon in 2 ml of 12.5% solution intramuscularly every other day, for a total of 5-10 injections. |
| priorityDate |
2001-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |